Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Workplace sitting and height-adjustable workstations: a randomized controlled trial
Neuhaus M, Healy GN, Dunstan DW, Owen N, Eakin EG
American Journal of Preventive Medicine 2014 Jan;46(1):30-40
clinical trial
4/10 [Eligibility criteria: Yes; Random allocation: No; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Desk-based office employees sit for most of their working day. To address excessive sitting as a newly identified health risk, best practice frameworks suggest a multi-component approach. However, these approaches are resource intensive and knowledge about their impact is limited. PURPOSE: To compare the efficacy of a multi-component intervention to reduce workplace sitting time, to a height-adjustable workstations-only intervention, and to a comparison group (usual practice). DESIGN: Three-arm quasi-randomized controlled trial in three separate administrative units of the University of Queensland, Brisbane, Australia. Data were collected between January and June 2012 and analyzed the same year. SETTING/PARTICIPANTS: Desk-based office workers aged 20 to 65 (multi-component intervention, n = 16; workstations-only, n = 14; comparison, n = 14). INTERVENTION: The multi-component intervention comprised installation of height-adjustable workstations and organizational-level (management consultation, staff education, manager e-mails to staff) and individual-level (face-to-face coaching, telephone support) elements. MAIN OUTCOME MEASURES: Workplace sitting time (minutes/8-hour workday) assessed objectively via activPAL3 devices worn for 7 days at baseline and 3 months (end-of-intervention). RESULTS: At baseline, the mean proportion of workplace sitting time was approximately 77% across all groups (multi-component group 366 minutes/8 hours (SD 49); workstations-only group 373 minutes/8 hours (SD 36), comparison 365 minutes/8 hours (SD 54)). Following intervention and relative to the comparison group, workplace sitting time in the multi-component group was reduced by 89 minutes/8-hour workday (95% CI -130 to -47 minutes; p < 0.001) and 33 minutes in the workstations-only group (95% CI -74 to 7 minutes, p = 0.285). CONCLUSIONS: A multi-component intervention was successful in reducing workplace sitting. These findings may have important practical and financial implications for workplaces targeting sitting time reductions. CLINICAL TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry 00363297.

Full text (sometimes free) may be available at these link(s):      help